502 related articles for article (PubMed ID: 2479244)
1. Evaluation of immune parameters (including specific IgG4) during immunotherapy.
Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA
Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244
[TBL] [Abstract][Full Text] [Related]
2. Effect of immunotherapy on antigen-specific IgG4 in asthmatics sensitive to D. pteronyssinus.
García BE; Sanz ML; Wong E; Oehling A
Allergol Immunopathol (Madr); 1988; 16(6):379-83. PubMed ID: 3242375
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between the prick test and specific IgE against allergens of house dust and Dermatophagoides sp].
Corominas Sánchez M; Torres Rodríguez JM; Barbera Salva G; Aixala Abello S; Mestre Playa M; Buendia Gracia E
Allergol Immunopathol (Madr); 1982; 10(4):269-76. PubMed ID: 7180792
[TBL] [Abstract][Full Text] [Related]
4. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
Ebner H; Neuchrist C; Havelec L; Kraft D
Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
[TBL] [Abstract][Full Text] [Related]
5. Analysis of house dust mite-specific IgE, IgG4, and IgG antibodies during immunotherapy in asthmatic children.
Lin KL; Wang SY; Hsieh KH
Ann Allergy; 1991 Jul; 67(1):63-9. PubMed ID: 1859043
[TBL] [Abstract][Full Text] [Related]
6. [The effect of intrabronchial specific immunotherapy on certain immunologic parameters in asthmatic patients with allergic to house mites].
Zietkowski Z
Pol Merkur Lekarski; 1999 May; 6(35):236-8. PubMed ID: 10437389
[TBL] [Abstract][Full Text] [Related]
7. House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes.
O'Brien RM; Byron KA; Varigos GA; Thomas WR
Clin Exp Allergy; 1997 Jan; 27(1):46-51. PubMed ID: 9117880
[TBL] [Abstract][Full Text] [Related]
8. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus.
Piazza I; Bizzaro N
Ann Allergy; 1993 Nov; 71(5):461-9. PubMed ID: 7755664
[TBL] [Abstract][Full Text] [Related]
9. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
[TBL] [Abstract][Full Text] [Related]
10. Influence of hyposensitization with Dermatophagoides pteronyssinus extract on clinical score, total and specific IgE levels, and skin test in asthmatic patients.
Delaunois L; Salamon E; Prignot J
Ann Allergy; 1985 Aug; 55(2):150-2. PubMed ID: 4025957
[TBL] [Abstract][Full Text] [Related]
11. [The histamine liberation test as a diagnostic parameter and its possible modification following specific immunotherapy].
Engel P; Malet A; Sanosa J; Fajas L; García-Calderón PA
Allergol Immunopathol (Madr); 1985; 13(2):93-100. PubMed ID: 2408457
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.
Tari MG; Mancino M; Monti G
Allergol Immunopathol (Madr); 1990; 18(5):277-84. PubMed ID: 2097894
[TBL] [Abstract][Full Text] [Related]
13. Comparative clinical-immunological study of oral and subcutaneous immunotherapy in children with extrinsic bronchial asthma.
Sánchez Palacios A; Schamann Medina F; Lamas Rua-Figueroa A; Bosch Millares C; Ramos Santos S; García Marrero JA
Allergol Immunopathol (Madr); 1989; 17(6):323-9. PubMed ID: 2635834
[TBL] [Abstract][Full Text] [Related]
14. Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes.
Machiels JJ; Somville MA; Lebrun PM; Lebecque SJ; Jacquemin MG; Saint-Remy JM
J Clin Invest; 1990 Apr; 85(4):1024-35. PubMed ID: 2318962
[TBL] [Abstract][Full Text] [Related]
15. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program.
Huss K; Adkinson NF; Eggleston PA; Dawson C; Van Natta ML; Hamilton RG
J Allergy Clin Immunol; 2001 Jan; 107(1):48-54. PubMed ID: 11149990
[TBL] [Abstract][Full Text] [Related]
16. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
[TBL] [Abstract][Full Text] [Related]
17. "In vivo" and "in vitro" evaluation of four antihistamines (astemizole, azatadine, mequitazine, terfenadine).
Malet i Casajuana A; Ruiz de León J; Valero Santiago A; Sanosa Valls J; Zamorano Calderón M; García Calderón PA
Allergol Immunopathol (Madr); 1989; 17(2):85-93. PubMed ID: 2476015
[TBL] [Abstract][Full Text] [Related]
18. Parameters of immunotherapy: a retrospective study.
Malet A; Lluch M; Valero A; Amat P
Allergol Immunopathol (Madr); 1993; 21(1):7-10. PubMed ID: 8328357
[TBL] [Abstract][Full Text] [Related]
19. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
[TBL] [Abstract][Full Text] [Related]
20. T cell responses to the major allergen from the house dust mite Dermatophagoides pteronyssinus, Antigen P1: comparison of patients with asthma, atopic dermatitis, and perennial rhinitis.
Rawle FC; Mitchell EB; Platts-Mills TA
J Immunol; 1984 Jul; 133(1):195-201. PubMed ID: 6609976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
